Escherichia: Doxorubicin resistance


Doxorubicin description

topoisomerase II inhibitor

Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN and is used in treatment of both leukemia and solid tumors.

Doxorubicin resistance gene: mdtf